SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Paracelsian Inc (PRLN)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Richard Mazzarella who wrote (388)9/5/1996 11:05:00 PM
From: WWS   of 4342
 
Richard, PRLN must give details of 90 day Phase 1 trial with PN355 before they'll get serious attention. And with so few patients involved it may be hard to make any solid conclusions because there certainly could not have been a control group. I'm also a little leery about Bastyr University. Did you know that their director of clinical research is not an MD or PhD? Nothing against him personally, but credentials of researchers are clearly important to the doctors and FDA officials who must pass judgement on the quality of research. Take care, Bill in St. Louis.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News